加载中
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
前收盘价
US$8.27
−US$0.03 · -0.36%
盘后
US$8.27
US$0.00 · 0.00%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
日内区间
当前US$8.27
52周区间
当前US$8.27
盘中时间采用ET。市场数据可能有所延迟。
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
日内区间
当前US$8.27
52周区间
当前US$8.27
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（EUR） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2.57亿 EUR | 2.67亿 EUR | 2.56亿 EUR | 2.32亿 EUR | 2.05亿 EUR |
| 销货成本 | 1.1亿 EUR | 1.16亿 EUR | 1.11亿 EUR | 1.03亿 EUR | 8727.8万 EUR |
| 毛利 | 1.47亿 EUR | 1.51亿 EUR | 1.45亿 EUR | 1.29亿 EUR | 1.18亿 EUR |
| 研究与开发 | 4427万 EUR | 4440万 EUR | 3809.8万 EUR | 3756.8万 EUR | 2689.1万 EUR |
| 销售、一般及管理费用 | 9631.7万 EUR | 1.01亿 EUR | 9489万 EUR | 9301.7万 EUR | 7758.7万 EUR |
| 营业费用 | 1.42亿 EUR | 1.41亿 EUR | 1.4亿 EUR | 1.32亿 EUR | 1.06亿 EUR |
| 利息收入 | 381.14万 EUR | 425.2万 EUR | 445万 EUR | 139.99万 EUR | 77.77万 EUR |
| 利息支出 | 539.44万 EUR | 165万 EUR | 208.9万 EUR | 291.65万 EUR | 336.04万 EUR |
| 折旧和摊销 | 2084.84万 EUR | 2176.1万 EUR | 2156.9万 EUR | 2256.8万 EUR | 2054.9万 EUR |
| 营业利润 | 494.39万 EUR | 943.2万 EUR | 561.9万 EUR | −287.2万 EUR | 1221.7万 EUR |
| 净利润 | 741.34万 EUR | 1343.6万 EUR | 672.2万 EUR | −212.3万 EUR | 1315.4万 EUR |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$10.00
上涨空间 20.92%报告持有此股票敞口的交易所交易基金。
The 3D Printing ETFPRNT277.11万4.58%6110万 USD0.66%US$25.23-1.06%
Pacer BlueStar Engineering the Future ETFBULD32.88万2.21%1487.87万 USD0.49%US$36.6199-1.66%
ActivePassive International Equity ETFAPIE25.38万0.02%11.41亿 USD0.45%US$38.40-0.41%
State Street SPDR S&P International Small Cap ETFGWX21.21万0.02%9.15亿 USD0.40%US$45.26-0.66%
State Street SPDR Portfolio Developed World ex-US ETFSPDW8.21万0.00%406.96亿 USD0.03%US$49.69-0.58%The 3D Printing ETFPRNTPacer BlueStar Engineering the Future ETFBULDActivePassive International Equity ETFAPIEState Street SPDR S&P International Small Cap ETFGWXState Street SPDR Portfolio Developed World ex-US ETFSPDWAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
